Literature DB >> 27640170

Designing of Epitope-Focused Vaccine by Targeting E6 and E7 Conserved Protein Sequences: An Immuno-Informatics Approach in Human Papillomavirus 58 Isolates.

Sabrina Nusrat Sabah1, Md Amran Gazi2, Rahvia Alam Sthity3, Amena Binte Husain4, Salwa Abdul Quyyum4, Mustafizur Rahman5, Md Rezaul Islam6.   

Abstract

Human papillomavirus (HPV) is a DNA virus that belongs to the papillomavirus family and is capable of infecting humans. Currently, few vaccines are available to prevent infection by HPV. However, they are not so much effective and provide little benefit to women who have already been infected with HPV. The aim of this study was to design epitope-based vaccines of HPV58 by targeting E6 and E7 proteins of HPV58. Proteomic sequences were retrieved from different isolates at different time periods and later analyzed by performing alignment of these sequences. To ensure the capacity of humoral and cell-mediated immunity, both B cell and T cell immunity were checked for the peptides. For E6 protein, the peptide sequence from 48 to 54 amino acids and one 9-m epitope ETSVHEIEL were the most potential B cell and T cell epitopes, respectively. This peptide could interact with as many as eight MHC-1 alleles and showed high population coverage up to 90.31 %. On the other hand, the peptide region for the E7 protein ranged from 27 to 33 amino acids and two 9-m epitopes QAQPATANY, SSDEDEIGL were found as the most potential B cell and T cell epitopes, respectively. The peptide sequences could interact with as many as seven MHC-1 alleles and showed population coverage up to 90.31 %. Furthermore, conservancy analysis was also performed using in silico tools and showed a conservancy of 100 % for all the selected epitopes. In addition to this, the allergenicity of the epitopes was also evaluated. Although the study requires further in vitro and in vivo screening, this epitope-focused peptide vaccine designing opens up a new skyline that holds a prospective future in HPV research.

Entities:  

Keywords:  Cervical cancer; Epitope-based vaccine; HLA; HPV58; In silico

Mesh:

Substances:

Year:  2016        PMID: 27640170     DOI: 10.1007/s12539-016-0184-5

Source DB:  PubMed          Journal:  Interdiscip Sci        ISSN: 1867-1462            Impact factor:   2.233


  5 in total

1.  Prediction and identification of human leukocyte antigen-A2-restricted cytotoxic T lymphocyte epitope peptides from the human papillomavirus 58 E7 protein.

Authors:  He Wang; Lilai Chen; Weihong Ma; Yue Zeng; Lu Qin; Mengjie Chen; Li Li
Journal:  Oncol Lett       Date:  2018-06-01       Impact factor: 2.967

2.  Designing of CD8+ and CD8+-overlapped CD4+ epitope vaccine by targeting late and early proteins of human papillomavirus.

Authors:  Satyavani Kaliamurthi; Gurudeeban Selvaraj; Aman Chandra Kaushik; Ke-Ren Gu; Dong-Qing Wei
Journal:  Biologics       Date:  2018-10-02

3.  Exploring the Papillomaviral Proteome to Identify Potential Candidates for a Chimeric Vaccine against Cervix Papilloma Using Immunomics and Computational Structural Vaccinology.

Authors:  Satyavani Kaliamurthi; Gurudeeban Selvaraj; Sathishkumar Chinnasamy; Qiankun Wang; Asma Sindhoo Nangraj; William Cs Cho; Keren Gu; Dong-Qing Wei
Journal:  Viruses       Date:  2019-01-15       Impact factor: 5.048

4.  In silico/In vivo analysis of high-risk papillomavirus L1 and L2 conserved sequences for development of cross-subtype prophylactic vaccine.

Authors:  Ali Namvar; Azam Bolhassani; Gholamreza Javadi; Zahra Noormohammadi
Journal:  Sci Rep       Date:  2019-10-23       Impact factor: 4.379

5.  Immunoinformatics prediction of potential B-cell and T-cell epitopes as effective vaccine candidates for eliciting immunogenic responses against Epstein-Barr virus.

Authors:  Fisayo A Olotu; Mahmoud E S Soliman
Journal:  Biomed J       Date:  2021-06-19       Impact factor: 4.910

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.